# HB Biotech, Inc. — Form D

HB Biotech, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-15. The offering totals $11.0M, of which $7.8M was reported sold. Industry: Other.

## Offering

- Filed: 2022-12-15
- Form: D
- Accession: 0001958314-22-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $11.0M
- Amount sold: $7.8M
- Remaining: $3.2M
- Investors: 17
- Date of first sale: 2022-12-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-467639

## Issuer

- Name: HB Biotech, Inc.
- CIK: 0001958314
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 515 WEST 20TH STREET, NEW YORK, NY, 10011
- Phone: 2126477777

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Tomer Seifan | Director | Hamilton, D0 |
| Tomer Seifan | Executive Officer | Hamilton, D0 |

## More

- [CIK 1958314 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1958314&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001958314-22-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.